Vimarsana
Biggest News Aggregation in the World

Tether Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tether Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tether Therapeutics Today - Breaking & Trending Today

The Escalator: Bayer, Stevanato Group, Qnovia and more - Vimarsana News

The Escalator: Bayer, Stevanato Group, Qnovia and more

See which leaders are on the move across the pharma, biotech and medical marketing industries.

PanTher Therapeutics Presents Positive First-in-Human Data for PTM-101 in Pancreatic Cancer at AACR Annual Meeting - Vimarsana News

PanTher Therapeutics Presents Positive First-in-Human Data for PTM-101 in Pancreatic Cancer at AACR Annual Meeting

AUSTIN, Texas--(BUSINESS WIRE)--Apr 8, 2024--

PanTher Therapeutics Announces Appointment of John Edwards as Executive Chair of the Board of Directors - Vimarsana News

PanTher Therapeutics Announces Appointment of John Edwards as Executive Chair of the Board of Directors

PanTher Therapeutics ("PanTher" or the "Company"), a clinical-stage oncology company developing high-dose, long lasting, localized treatments for cancer, announced that John Edwards has been appointed as the Executive Chair of the Board of Directors....

World's Largest Medtech Accelerator Announces 61 Startups for its 2023 Cohort - Vimarsana News

World's Largest Medtech Accelerator Announces 61 Startups for its 2023 Cohort

MedTech Innovator, the world’s largest accelerator of medical technology companies, today announced the 2023 Accelerator Cohort. After a competitive selection process, 61 companies were chosen to participate in the MedTech Innovator’s flagship four-month MedTech Accelerator program. Featuring medical device ...

Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q4 2022 Earnings Call Transcript - Vimarsana News

Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q4 2022 Earnings Call Transcript

Operator: Welcome to the Lineage Cell Therapeutics Fourth Quarter and Full Year 2022 Conference Call. At this time, all participants are in a listen-only mode.